Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesProgyny Inc

Progyny Inc

Healthcare Health Information Services
PortfolioPortfolio WatchlistWatchlist
Company price
35.6 USD 0.76 ( 2.18%)
Last update at 2026-11-09T15:24:00Z
VOLUME
219933
Market Cap
2539.54M
P/E
44.45

Momentum Score

…

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
34.88
Low
35.95
High
52 Week Price Range
23.90
Low
44.95
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
34.84
Dividend Yield
-
Revenue TTM
1108.28M
Revenue Per Share
11.58
Gross Profit TTM
167.32M
Debt / Equity
0.04
ROE
12.30%
Net Debt
-77.91M
ROCE
4.09%
Diluted EPS TTM
0.60

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 24.44M 32.44M 8.68M -8.56M -6.89M
Net income 30.36M 65.77M 46.46M -8.57M 0.66M
Selling general administrative 98.33M 59.62M 46.70M 23.93M 15.60M
Selling and marketing expenses 45.66M 20.18M 15.01M 11.90M 7.29M
Gross profit 167.32M 112.14M 70.06M 45.51M 19.43M
Reconciled depreciation 1.60M 1.30M 1.91M 2.13M 1.88M
Ebit 23.34M 32.34M 8.35M 27.85M -0.51M
Ebitda 24.94M 33.64M 10.25M 29.99M 1.38M
Depreciation and amortization 1.60M 1.30M 1.91M 2.13M 1.88M
Non operating income net other 0.29M -0.37M 0.21M - -
Operating income 23.34M 32.34M 8.35M 27.85M -3.45M
Other operating expenses 763.57M 468.28M 336.51M 220.01M 108.85M
Interest expense 0.81M 0.46M 0.12M -0.50M 0.00M
Tax provision -5.92M -33.33M -37.78M 0.01M -1.78M
Interest income 0.81M - - 0.06M 0.50M
Net interest income 0.81M 0.46M 0.12M -0.06M -0.50M
Extraordinary items - - - - 5.78M
Income tax expense -5.92M -33.33M -37.78M 0.01M -1.78M
Total revenue 786.91M 500.62M 344.86M 229.68M 105.40M
Total operating expenses 143.98M 79.80M 61.71M 35.83M 22.89M
Cost of revenue 619.59M 388.49M 274.80M 184.18M 85.97M
Total other income expense net 1.10M 0.10M 0.33M -36.41M -2.94M
Discontinued operations - - - - 5.78M
Net income from continuing ops 30.36M 65.77M 46.46M -8.57M -5.12M
Net income applicable to common shares 30.36M 65.77M 46.46M -8.57M 0.24M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 756.62M 542.99M 358.06M 253.93M 150.43M
Intangible assets - 0.10M 0.60M 1.21M 2.38M
Other current assets 27.45M 4.49M 4.56M 5.26M 5.00M
Total liab 203.19M 166.02M 106.24M 86.98M 36.16M
Total stockholder equity 553.43M 376.97M 251.82M 166.95M 114.27M
Other current liab 1.18M 49.02M 2.17M 34.27M 16.77M
Common stock 0.01M 0.01M 0.01M 0.01M 0.01M
Capital stock 0.01M 0.01M 0.01M 0.01M 0.01M
Retained earnings 89.97M 27.93M -2.42M -68.19M -113.48M
Other liab - - - 0.88M -
Good will 11.88M 11.88M 11.88M 11.88M 11.88M
Other assets - 81.88M 74.22M 8.22M 0.65M
Cash 97.30M 120.08M 91.41M 70.31M 80.38M
Total current liabilities 185.95M 159.54M 98.82M 77.79M 36.16M
Current deferred revenue 57.19M - 34.02M - -
Net debt -77.91M -112.36M -83.99M -61.99M -80.38M
Short term debt 2.15M 1.23M 1.23M 0.25M -
Short long term debt total 19.39M 7.71M 7.42M 8.32M -
Other stockholder equity 460.63M 348.52M 254.33M 235.13M 227.75M
Property plant equipment - 8.37M 12.83M 3.40M 3.08M
Total current assets 640.41M 433.86M 258.54M 190.22M 132.44M
Net tangible assets - 364.99M 239.34M 153.85M 100.02M
Short term investments 273.79M 69.22M 28.00M 38.99M -
Net receivables 241.87M 240.07M 134.56M 75.66M 47.06M
Inventory 0.00M - - - -
Accounts payable 125.43M 109.29M 61.40M 43.51M 19.39M
Accumulated other comprehensive income 2.82M 0.50M -0.09M 0.00M -150.43M
Common stock total equity - 0.01M 0.01M 0.01M 0.01M
Retained earnings total equity - 27.93M -2.42M -68.19M -
Treasury stock - - - - -1.01M
Non currrent assets other 3.40M 3.99M 2.94M 0.57M 0.65M
Non current assets total 116.21M 109.13M 99.53M 63.70M 17.99M
Capital lease obligations 19.39M 6.48M 8.65M 8.32M -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -43.87M 10.89M -38.99M -2.76M 1.90M
Change to liabilities 60.84M 17.84M 42.41M 3.50M 10.45M
Total cashflows from investing activities -43.87M 8.77M -40.03M -2.76M 1.90M
Net borrowings - - - -0.25M -5.10M
Total cash from financing activities -7.86M -13.70M -6.25M 84.55M -8.74M
Change to operating activities 12.12M -0.42M 17.68M 1.89M 2.68M
Net income 30.36M 65.77M 46.46M -8.57M 0.66M
Change in cash 28.66M 21.11M -10.08M 80.25M -4.56M
Begin period cash flow 91.41M 70.31M 80.38M 0.13M 4.69M
End period cash flow 120.08M 91.41M 70.31M 80.38M 0.13M
Total cash from operating activities 80.39M 26.04M 36.20M -1.53M 2.27M
Issuance of capital stock - 0.00M 0.00M 78.39M 0.00M
Depreciation 1.60M 1.30M 1.91M 2.13M 1.88M
Other cashflows from investing activities - - - 0.20M 2.48M
Change to inventory - 2.86M 17.07M 2.27M 2.58M
Change to account receivables -119.30M -68.68M -35.34M -25.34M -12.78M
Sale purchase of stock 4.22M 4.27M 2.68M -0.18M -3.71M
Other cashflows from financing activities -10.94M -13.70M -6.25M 188.62M 64.49M
Change to netincome 107.93M 10.22M -19.51M 24.86M -0.70M
Capital expenditures 3.24M 2.13M 1.04M 2.96M 0.58M
Change receivables -119.30M -68.68M -35.34M - -
Cash flows other operating -1.02M -2.60M 0.28M - -
Cash and cash equivalents changes 28.66M 21.11M -10.08M - -
Change in working capital -59.49M -51.26M 7.35M -19.95M 0.35M
Stock based compensation 100.75M 33.71M 12.82M 5.06M 3.00M
Other non cash items 13.79M 9.82M 5.64M 19.78M -1.85M
Free cash flow 77.15M 23.91M 35.17M -4.49M 1.69M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PGNY
Progyny Inc		 0.76
2.18%		 35.60 44.45 48.08 3.03 5.96 2.71 45.71
VEEV
Veeva Systems Inc Class A		 -1.60
0.53%		 302.12 43.49 29.59 12.48 5.79 10.39 33.41
PMCUF
Pro Medicus Limited		 -
-%		 144.00 64.90 90.91 49.11 38.05 65.12 83.47
TEM
Tempus AI, Inc. Class A Common Stock		 6.32
8.31%		 82.37 - - 8.68 25.39 8.33 -
MTHRY
M3 Inc		 0.30
5.27%		 5.99 31.84 26.25 0.05 4.60 0.04 0.12

Profile*

Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

1359 Broadway, New York, NY, United States, 10018

212 888 3124

https://www.progyny.com

563

Name Title Year Born
Mr. David J. Schlanger Exec. Chairman 1959
Mr. Peter Anevski CEO & Director 1967
Mr. Mark S. Livingston Chief Financial Officer 1966
Mr. Michael Sturmer Pres 1977
Mr. James Hart VP of Investor Relations NA
Ms. Risa Fisher Exec. VP & Chief Marketing Officer NA
Ms. Cassandra Pratt Sr. VP of People NA
Ms. Julie Stadlbauer Exec. VP of Strategic Sales & Partnerships NA
Ms. Arielle Bogorad Sr. VP of Employer Market Strategy NA
Allison Swartz Exec. VP & GC NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

GFR
CAD 10.96
+38.15%
MOON
CAD 4.83
+9.64%
PDN
CAD 8.13
+7.68%
BDT
CAD 72.82
+6.65%
HG
CAD 4.28
+6.20%
CSU
CAD 3300.00
-6.42%
CURA
CAD 12.68
-4.16%
DIV
CAD 3.93
-3.44%
SOIL
CAD 7.18
-3.10%
OBE
CAD 13.31
-2.92%

Equity Sectors*

  • Basic Materials

    +3.19%

  • Communication Services

    -0.04%

  • Consumer Cyclical

    +0.27%

  • Consumer Defensive

    -0.21%

  • Energy

    +1.16%

  • Financial Services

    +0.81%

  • Healthcare

    +0.03%

  • Industrials

    +1.64%

  • Real Estate

    +0.06%

  • Technology

    +0.38%

  • Utilities

    +0.68%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…